Altered neutrophil homeostasis in kinin B1 receptor-deficient mice

被引:63
作者
Araújo, RC
Kettritz, R
Fichtner, I
Paiva, ACM
Pesquero, JB
Bader, M
机构
[1] Univ Fed Sao Paulo, Escola Paulista Med, Dept Biophys, BR-04023062 Sao Paulo, Brazil
[2] Max Delbruck Ctr Mol Med, Mol Biol Peptide Hormones Grp, D-13092 Berlin, Germany
[3] Max Delbruck Ctr Mol Med, Franz Volhard Clin, D-13092 Berlin, Germany
基金
巴西圣保罗研究基金会;
关键词
B1; receptor; bradykinin; gene targeting; immune system; inflammation; leukocytes;
D O I
10.1515/BC.2001.014
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The kallikrein-kinin system is activated during inflammation and plays a major role in the inflammatory process. One of the main mechanisms of kinin action includes the modulation of neutrophil function employing both receptors for kinins, B1 and B2, In this report we show by the use of B1 receptor-deficient mice that neutrophil migration in inflamed tissues is dependent on kinin B1 receptors, However, there is no change in circulating leukocyte number and composition after genetic ablation of this receptor. Furthermore, apoptosis of neutrophils necessary for the resolution of persistent inflammatory processes is impaired in mice lacking the B1 receptor. We also show that this receptor is expressed on neutrophils, thus it may be directly involved in the induction of apoptosis in these cells after prolonged activation at inflamed sites. In conclusion, our data show that the kinin B1 receptor modulates migration and the life span of neutrophils at sites of inflammation and may be therefore an important drug target in the therapy of inflammatory diseases.
引用
收藏
页码:91 / 95
页数:5
相关论文
共 20 条
[1]  
Ahluwalia A, 1996, J IMMUNOL, V156, P269
[2]   Structure and genomic organization of the human B-1 receptor gene for kinins (BDKRB1) [J].
Bachvarov, DR ;
Hess, JF ;
Menke, JG ;
Larrivee, JF ;
Marceau, F .
GENOMICS, 1996, 33 (03) :374-381
[3]   Pharmacological and molecular evidence for kinin B1 receptor expression in urinary bladder of cyclophosphamide-treated rats [J].
Belichard, P ;
Luccarini, JM ;
Defrêne, E ;
Faye, P ;
Franck, RM ;
Duclos, H ;
Paquet, JL ;
Pruneau, D .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 128 (01) :213-219
[4]  
BHOOLA KD, 1992, PHARMACOL REV, V44, P1
[5]  
FIGUEROA CD, 1992, BLOOD, V79, P754
[6]   SENSORY NEUROPEPTIDE RELEASE BY BRADYKININ - MECHANISMS AND PATHOPHYSIOLOGICAL IMPLICATIONS [J].
GEPPETTI, P .
REGULATORY PEPTIDES, 1993, 47 (01) :1-23
[7]  
Kettritz R, 1997, J AM SOC NEPHROL, V8, P1091
[8]   ANNEXIN-V FOR FLOW CYTOMETRIC DETECTION OF PHOSPHATIDYLSERINE EXPRESSION ON B-CELLS UNDERGOING APOPTOSIS [J].
KOOPMAN, G ;
REUTELINGSPERGER, CPM ;
KUIJTEN, GAM ;
KEEHNEN, RMJ ;
PALS, ST ;
VANOERS, MHJ .
BLOOD, 1994, 84 (05) :1415-1420
[9]  
LILES WC, 1995, J IMMUNOL, V155, P3289
[10]  
Marceau F, 1998, PHARMACOL REV, V50, P357